Iterum Therapeutics GAAP EPS of -$0.30 beats by $0.15 (NASDAQ:ITRM)
Iterum Therapeutics press release (NASDAQ:ITRM): Q2 GAAP EPS of -$0.30 beats by $0.15. Cash, cash equivalents and short-term investments were…
Iterum Therapeutics press release (NASDAQ:ITRM): Q2 GAAP EPS of -$0.30 beats by $0.15. Cash, cash equivalents and short-term investments were…